Bio Protocol has announced the launch of the Ignition Sale for Aubrai, the world's first decentralized BioAgent focused on advancing longevity research.
About the Ignition Sale
Bio Protocol has initiated the Ignition Sale for Aubrai, a decentralized AI agent dedicated to longevity research. Participants can pledge BioXP or BIO tokens, with a maximum contribution of 5,850 BIO per participant. All contributions must be completed by August 26 at 11:00 UTC to qualify for allocation.
What is Aubrai?
Aubrai, co-developed with VitaDAO and informed by Dr. Aubrey de Grey's research, is a decentralized BioAgent that employs mechanisms to bridge traditional funding gaps. Aubrai can generate and validate research hypotheses, design lab experiments, and protect data securely.
Aubrai’s Goals and Capabilities
Aubrai aims to accelerate longevity science through participation in the RMR2 project, which seeks to extend the lifespan of middle-aged mice. AUBRAI token holders gain governance rights over research outcomes and potential revenues from commercialized discoveries.
The launch of the Ignition Sale for Aubrai highlights new approaches to financing scientific research and illustrates the potential of decentralized solutions in the field of longevity.
